Header Logo

Connection

Yehuda Handelsman to Serotonin 5-HT2 Receptor Agonists

This is a "connection" page, showing publications Yehuda Handelsman has written about Serotonin 5-HT2 Receptor Agonists.
  1. Lorcaserin treatment allows for decreased number needed to treat for weight and glycemic parameters in week 12 responders with =5% weight loss. Postgrad Med. 2016 Nov; 128(8):740-746.
    View in: PubMed
    Score: 0.531
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.